The real lessons from Tongaat and Murray & Roberts’ distress

‘I would say it is a crisis of sorts, because it's been a long-running problem and there doesn't at the moment seem to be any end in sight,’ says Chris Oxtoby, research consultant at Freedom Under Law.

ConCourt crisis deepens as caseloads explode and delays mount. Inside the split-second moment that drives pharmacy sales. And too much pressure on SMEs puts SA’s jobs strategy under scrutiny.

‘Young people are not joining the medical aid scheme and the ones who are in the medical aid scheme are dropping out. This results in a spiral effect in which the contributions or the premiums become more expensive,’ says Luyanda Njilo, senior equity research analyst for healthcare at Nedbank Corporate…

Funding uncertainty threatens Cape Town’s MyCiTi success story. Why younger South Africans are leaving medical aid. And how stress fuels surge in addictive behaviours among SA workers.

‘I think the main concern with compounded GLP-1s, is that they are not actually assessed or tested by the applicable regulators,’ says Charles Green, healthcare and pharmaceutical expert at Cliffe Dekker Hofmeyr.